E-DRUG: Independent Drug and Healthcare Newsletter for May 2018
-----------------------------------------------------------------------------------
Independent Drug & Healthcare Newsletter from the non-profit journal Prescrire International
Newsletter, May 2018
View the contents
If your friends or colleagues would be interested, forward this email and invite them to sign up for the free Newsletter.
Like what you see?
Subscribe to Prescrire International
In Prescrire's Spotlight this month
--------------------------------------------------------------------------------
FEATURED REVIEW Metopimazine: cardiac disorders
Metopimazine has received much less attention than domperidone in regard to its cardiovascular adverse effects, but the limited data available suggest that it probably exposes patients to a risk similar to that of domperidone.
Read more
--------------------------------------------------------------------------------
FREE DOWNLOAD In the May issue of Prescrire International:
Psychiatric disorders following in utero exposure to diethylstilbestrol (DES)
In utero exposure to DES results in a variety of harmful effects, including long-term harms. Psychiatric disorders reported for "DES daughters" and "DES sons" include depression, bipolar disorder, behavioural disorders and schizophrenia.
Read more
--------------------------------------------------------------------------------
Exploratory trials, surrogate endpoints: not a robust basis for marketing authorisation
To serve the best interests of patients, it is more necessary than ever to base marketing authorisation decisions on robust data.
Read more
--------------------------------------------------------------------------------
New cancer drugs: poorly evaluated, ineffective and overpriced
Many new cancer drugs are sold by drug companies at exorbitant prices, while their therapeutic benefit - when there is one - is usually modest.
Read more
--------------------------------------------------------------------------------
Warts: beware of acid-based wart removers
In recent years, in France and elsewhere, deep burns and necrosis, sometimes with permanent after-effects, have been reported with concentrated acid-based topical wart removers.
Read more
Share this with a friend or colleague: Forward this email
Prescrire International <international@prescrire.org>